Dr. Clint Lane Ledford, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 230 Highway 64 E, Hayesville, NC 28904 Phone: 828-389-2804 Fax: 828-389-2832 |
William Amundsen Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 808 Nc Hwy 69, Hayesville, NC 28904 Phone: 828-389-6900 Fax: 828-369-6966 |
Constance Maccorkle, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 44 Highway 64 W, Hayesville, NC 28904 Phone: 828-389-6343 Fax: 828-389-9460 |
Kyle Eve Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 44 Highway 64 W, Hayesville, NC 28904 Phone: 828-389-6343 |
Linda P Mckeever, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 44 Highway 64 W, Hayesville, NC 28904 Phone: 828-389-6343 |
Dr. Rebekah A Thompson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 808 Nc Hwy 69, Hayesville, NC 28904 Phone: 828-389-6900 |
Dr. Chanda Wadsworth, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 230 Highway 64 E, Hayesville, NC 28904 Phone: 828-389-2804 Fax: 828-389-2832 |
Ronald Lee Taylor, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 230 Highway 64 E, Hayesville, NC 28904 Phone: 828-389-2804 Fax: 828-389-2832 |
Diana Elizabeth Brown, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 250 Us Highway 64 East, Hayesville, NC 28904 Phone: 828-389-0550 |
Donnie Herbert Payne, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 230 Highway 64 E, Hayesville, NC 28904 Phone: 828-389-2804 Fax: 828-389-2832 |
Margaret Ann Harris, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 44 Highway 64 W, Hayesville, NC 28904 Phone: 828-389-6343 Fax: 828-389-9460 |
News Archive
Array BioPharma Inc. today announced presentations on encorafenib, binimetinib and selumetinib (licensed to AstraZeneca) at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held May 29 – June 2, 2015 in Chicago, Illinois.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced the Company has completed enrollment in a Phase 1 study of KAI-4169, a novel pharmaceutical agent for the treatment of secondary hyperparathyroidism, which is a frequent complication of end stage renal disease.
EntreMed, Inc. has announced that it has initiated a Phase 1 study of ENMD-2076 in refractory multiple myeloma patients.
A virtual patient named Denise may help future physicians feel more comfortable and capable assessing suicide risk.
To enable elderly people to live at home as long as possible, a group of European researchers, coordinated from Eindhoven University of Technology, will link robots and 'smart homes'. The robot, a 'sensible family friend', will ensure that home is a nice place to stay. And that patients do the right things.
› Verified 6 days ago